# PARADIGM BIOPHARMACEUTICALS LIMITED..

> Australian public company

**Wikidata**: [Q109627079](https://www.wikidata.org/wiki/Q109627079)  
**Source**: https://4ort.xyz/entity/paradigm-biopharmaceuticals-limited

## Summary
PARADIGM BIOPHARMACEUTICALS LIMITED is an Australian public company. Its securities are traded on the Australian Securities Exchange under the stock code 'PAR'. The company operates in the biopharmaceutical sector.

## Key Facts
*   PARADIGM BIOPHARMACEUTICALS LIMITED is an Australian public company.
*   Its official name is "PARADIGM BIOPHARMACEUTICALS LIMITED..".
*   The company's securities are listed on the Australian Securities Exchange (ASX).
*   Its ASX stock ticker code is 'PAR'.
*   The listing commenced on August 19, 2015.
*   As of November 18, 2021, its market capitalization was 522,688,046 Australian dollars.
*   Its International Securities Identification Number (ISIN) is AU000000PAR5.
*   The company's official website is https://paradigmbiopharma.com/.

## FAQs
**What is PARADIGM BIOPHARMACEUTICALS LIMITED?**
It is an Australian public company, meaning it offers its securities for sale to the general public. The company is focused on the biopharmaceutical industry.

**Where are PARADIGM BIOPHARMACEUTICALS LIMITED's shares traded?**
The company's shares are publicly traded on the Australian Securities Exchange. Its listing on the ASX provides liquidity and allows investors to buy and sell its stock.

**What was the market value of PARADIGM BIOPHARMACEUTICALS LIMITED?**
As of a specific point in time, November 18, 2021, the company's market capitalization was reported as 522,688,046 Australian dollars. Market capitalization represents the total market value of a company's outstanding shares.

## Why It Matters
As a publicly traded biopharmaceutical company, PARADIGM BIOPHARMACEUTICALS LIMITED plays a role in the healthcare and investment sectors. Public listing enables the company to raise capital from a broad investor base to fund research, development, and commercialization efforts. This structure contributes to the development of new therapies and provides an investment vehicle within the Australian economy.

## Notable For
*   Being a publicly listed entity on the Australian Securities Exchange.
*   Operating within the specialized biopharmaceutical industry.
*   Having a specific market valuation as tracked by financial markets.

## Body

### Corporate Identity and Classification
PARADIGM BIOPHARMACEUTICALS LIMITED is legally classified as a public company. This distinguishes it from a private company, as its ownership shares are available for purchase by the general public on a stock exchange. The entity's full official name is recorded as "PARADIGM BIOPHARMACEUTICALS LIMITED..".

### Stock Exchange Listing
The company is listed on the Australian Securities Exchange (ASX), which is the primary stock exchange in Australia. Its shares began trading on the ASX on August 19, 2015. The specific ticker symbol assigned to the company for trading is 'PAR'.

### Financial Information
A key financial metric for any public company is its market capitalization. For PARADIGM BIOPHARMACEUTICALS LIMITED, this was documented as 522,688,046 Australian dollars on November 18, 2021. The company also has a unique International Securities Identification Number (ISIN), which is AU000000PAR5, used to identify its securities internationally.

### Official Communication Channel
The company maintains an official website at https://paradigmbiopharma.com/. This site serves as a primary source of information for investors, stakeholders, and the public regarding the company's activities, particularly in the biopharmaceutical domain.

## References

1. [Source](https://www2.asx.com.au/markets/trade-our-cash-market/directory)